Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 25;100(25):e26378.
doi: 10.1097/MD.0000000000026378.

Pyloric gland adenoma with low-grade intraepithelial neoplasia: A case report and literature review

Affiliations
Review

Pyloric gland adenoma with low-grade intraepithelial neoplasia: A case report and literature review

Hai-Long Li et al. Medicine (Baltimore). .

Abstract

Rationale: Pyloric gland adenoma (PGA) is often associated with pyloric gland metaplasia. It has high malignant potential but a low clinical diagnosis rate. Therefore, we reported a case of PGA and reviewed the literature to summarize the clinicopathological features of pyloric adenoma.

Patient concerns: A 62-year-old female underwent gastroscopy due to intermittent acid regurgitation and heartburn, which revealed a 4×6 mm flat, elevated lesion in the greater curvature of the upper gastric body, with depression in the central region and blood scab attachment.

Diagnosis and intervention: Biopsy revealed gastric adenoma with low-grade intraepithelial neoplasia. The patient was treated with ESD, and pathology showed gastric pyloric gland adenoma with low-grade dysplasia. The cells were positive for MUC6 and MUC5AC immunohistochemically.

Outcomes: The patient received proton pump inhibitors and gastric mucosal protective agents for one month after ESD. She occasionally presented acid regurgitation and heartburn, with no abdominal pain, abdominal distension, melena, or hematochezia. Follow-up gastroscopy will be reexamined 1 year later.

Lessons: PGA has nonspecific performance under endoscopy, and its diagnosis mainly depends on pathology. Clinicians need to increase their ability to recognize such lesions and treat them in time to improve the prognosis.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
(A) The lesion was located in the great curvature of the upper segment of the gastric body, as shown by the arrow. (B) Observation showed that the lesion was type IIa, colorless change, old blood could be seen at the central depression, and the lesion size was 4×6 mm in size. In FICE mode image (C), the demarcation line of the lesion was positive, and the surface pattern was dense and slightly disordered.
Figure 2
Figure 2
Pathological images showing PGA with low-grade intraepithelial neoplasia (A) (100×); (B) (200×). HE staining showed dense tubular glands covered with monolayer cuboidal to low columnar epithelial cells, mild structural disorder, slightly elongated nuclei, no obvious nucleoli, light staining to eosinophilic cytoplasm, ground glass shape, and no apical mucinous cap. (C–F) Immunohistochemistry. (C) (100×) Ki67 positivity of less than 1%. (D) (100×) MUC2 negative. (E) (100×) MUC5AC positive. (F) (100×) MUC6 positive.

References

    1. Nakajo K, Oono Y, Kuwata T. Case of pyloric gland adenoma accompanied by a component of foveolar epithelial-type adenoma within the lesion. Dig Endosc 2018;30:673. - PubMed
    1. Choi W-T, Brown I, Ushiku T, et al. . Gastric pyloric gland adenoma: a multicenter clinicopathological study of 67 cases. Histopathology 2018;72:1007–14. - PubMed
    1. Chen Z-M, Scudiere JR, Abraham SC, Montgomery E. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 2009;33:186–93. - PubMed
    1. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity!. J Clin Pathol 2014;67:883–90. - PubMed
    1. Pezhouh MK, Y J. Gastric pyloric gland adenoma. Arch Pathol Lab Med 2015;139:823–6. - PubMed

MeSH terms

Substances